Growth Hormone Therapy Is Safe and Effective in Patients with Lysinuric Protein Intolerance

Background: Lysinuric protein intolerance (LPI) is an autosomal recessive cationic amino acid transport defect characterized by episodes of postprandial hyperammonemias and spontaneous protein aversion. Subnormal growth is common in spite of appropriate nutritional therapy. Growth hormone (GH) thera...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Niinikoski, Harri, Lapatto, Risto, Nuutinen, Matti, Tanner, Laura, Simell, Olli, Näntö-Salonen, Kirsti
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Berlin Heidelberg 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3509816/
https://ncbi.nlm.nih.gov/pubmed/23430827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2011_15
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge